Inicio>>Signaling Pathways>> Others>>OB 24 hydrochloride

OB 24 hydrochloride

Catalog No.GC50348

El clorhidrato de OB 24 es un potente inhibidor de la hemooxigenasa-1 (HO-1). La hemooxigenasa-1, miembro de la familia de proteÍnas de choque térmico, desempeÑa un papel clave como sensor y regulador del estrés oxidativo. El clorhidrato de OB 24 inhibiÓ significativamente la proliferaciÓn celular in vitro y el crecimiento tumoral y las metÁstasis en los ganglios linfÁticos/pulmones in vivo. El clorhidrato de OB 24 tiene potencial para la investigaciÓn del cÁncer de prÓstata avanzado (PCA).

Products are for research use only. Not for human use. We do not sell to patients.

OB 24 hydrochloride Chemical Structure

Cas No.: 939825-12-4

Tamaño Precio Disponibilidad Cantidad
10 mg
244,00 $
Disponible
50 mg
1.028,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Potent and selective heme oxygenase 1 (HO-1) inhibitor (IC50 values are 1.9 and >100 μM for HO-1 and HO-2 respectively), reduces protein carbonylation and reactive oxygen species formation in advanced prostate cancer cells (PCA). Inhibits cell proliferation in vitro and PCA tumor growth and lymph node/lung metastases in vivo. Synergizes with Taxol .

Alaoui-Jamali et al (2009) A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Res. 69 8017 PMID:19808972

Reseñas

Review for OB 24 hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for OB 24 hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.